Smrithi Beeram

1PUBLICATIONS
10CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 25, 2026
Reduced Tumor Control in Males Can Result from Impaired CD4+ T-cell Help through the CD40L-CD40 Pathway.

Katey S Hunt, Samantha Cooke, Lindsey M Kuehm

Pageof 1

Frequent Collaborators

1 joint publications

Katey S Hunt

1 joint publications

Samantha Cooke

1 joint publications

Lindsey M Kuehm

1 joint publications

Tyson A Lobb

1 joint publications

Emily Ebert

1 joint publications

Ryan M Teague

1 joint publications

Michelle Brennan

1 joint publications

Melissa M Berrien-Elliott

1 joint publications

Stephen T Ferris

1 joint publications

Elise Alspach

Frequent Collaborators

1 joint publications

Katey S Hunt

1 joint publications

Samantha Cooke

1 joint publications

Lindsey M Kuehm

1 joint publications

Tyson A Lobb

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

2.2K
See more related videos

Top Related Videos

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

2.2K
See more related videos